NVET

Nexvet Biopharma plc Ordinary Shares
NVET

Delisted

NVET was delisted on the 28th of July, 2017.

0 hedge funds and large institutions have $0 invested in Nexvet Biopharma plc Ordinary Shares in 2017 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 20 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
Holders Change
-20
Holders Change %
-100%
% of All Funds
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
20
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Shares
Change %
FCM
1
Farallon Capital Management
California
-$17.7M -2,648,696 Closed
BC
2
Broadfin Capital
New York
-$7.54M -1,127,200 Closed
Adage Capital Partners
3
Adage Capital Partners
Massachusetts
-$5.32M -795,000 Closed
KAM
4
Kassirer Asset Management
Ontario, Canada
-$803K -120,000 Closed
HCMT
5
Highland Capital Management (Texas)
Texas
-$702K -105,000 Closed
GF
6
Gabelli Funds
New York
-$588K -87,900 Closed
PAMP
7
Polar Asset Management Partners
Ontario, Canada
-$569K -85,000 Closed
GCIA
8
Gabelli & Co Investment Advisers
New York
-$476K -71,100 Closed
GP
9
GLG Partners
United Kingdom
-$402K -60,098 Closed
SMC
10
S. Muoio & Co
New York
-$387K -57,790 Closed
HM
11
Harvest Management
New York
-$335K -50,000 Closed
GCL
12
Glazer Capital LLC
New York
-$284K -42,605 Closed
Norges Bank
13
Norges Bank
Norway
-$229K -34,313 Closed
DAM
14
DLD Asset Management
New York
-$174K -26,000 Closed
PCM
15
Prelude Capital Management
New York
-$153K -22,876 Closed
Deutsche Bank
16
Deutsche Bank
Germany
-$23K -3,500 Closed
Morgan Stanley
17
Morgan Stanley
New York
-$21K -3,178 Closed
UBS Group
18
UBS Group
Switzerland
-$16K -2,445 Closed
FPF
19
FNY Partners Fund
New York
-$15K -2,300 Closed
Bank of America
20
Bank of America
North Carolina
-$5K -800 Closed